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Please refer to the article on page 245 of this
issue to view the questions to which these answers
refer.
EVOLUTION
As mentioned, on the tenth day of the disease, the
Brucella tube agglutination test was negative, but
after 1 week, seroconversion at a titer of 1/320
occurred. Eight days after hospitalization, Brucella
melitensis was recovered from blood cultures by
the BACTEC technique (blood cultures had been
performed on the day that the patient came to
hospital).
The patient was treated with doxycycline and
rifampin for 6weeks. The rash disappeared 5days
after the start of therapy, and fever resolved on the
seventh day of therapy.
Final diagnosis: rash caused by brucellosis.
ANSWERS TO QUESTIONS
1. This is an atypical case of brucellosis redundant
because of the clinical presentation. However, the
patient had clear risk factors for the disease: hewas
a shepherd and reported consumption of cheese
made from raw milk. Physical examination
revealed a fever of 39 8C and splenomegaly, and
he came from a region with endemic Brucella
(Konya, Turkey). The symptoms of brucellosis
are non-speciﬁc; therefore, it is important to obtain
a detailed history that includes occupation, expo-
sure to animals, travel to enzootic areas, and inges-
tion of high-risk foods [1–3].
2. The diagnosis of brucellosis is made with
certainty when Brucella is recovered from blood,
bone marrow or other tissues. The rate of isolation
from blood ranges from 15 to 70%, depending on
the methods used and the period of incubation [4].
A variety of serologic tests have been applied to
the diagnosis of brucellosis, of which the Brucella
tube agglutination test is the most widely used. It
is usually positive after 1month from the start of
infection. In the early stages of infection, the ser-
ologic tests may be negative, and seroconversion
(over 1/160 titer) supports the diagnosis.
The Rose–Bengal test is a rapid screening
method; however, positive sera should always
be conﬁrmed by means of the Brucella tube agglu-
tination test.
3. The symptoms of brucellosis are non-speciﬁc.
Brucellosis is a systemic infection in which any
organ or system of the body can be involved. The
skeletal system is frequently involved [4], and
osteoarticular complications occur in 20–60% of
the patients. Cutaneous lesions occur in about 5%
of patients with brucellosis. Many transient, non-
speciﬁc lesions are described [2], including rashes,
papules, ulcers, erythema nodosum, petechiae,
purpura and vasculitis [1–3,5].
4. Antimicrobial therapy of brucellosis relieves
symptoms, shortens the duration of illness and
reduces the incidence of complications. It is
believed that the intracellular localization of Bru-
cella offers some protection against antimicrobials,
and drugs with good intracellular penetration are
necessary for a cure. The rate of relapse with
single-drug therapy is high, so combinations of
agents are generally recommended. Tetracycline
plus streptomycin or doxycycline plus rifampin
are recommended, and trimethoprim–sulfa-
methoxazole in combination with an aminoglyco-
side has been reported to be successful in treating
children younger than 8 years of age. Quinolones
and third-generation cephalosporins are also
recommended [4].
DISCUSSION
Brucellosis is a world-wide disease caused by
Brucella, a small Gram-negative, non-motile cocco-
bacillus, adapted to intracellular replication [1,2].
Brucella spp. are primarily animal pathogens,
and can be transmitted by means of consum-
ption of raw milk and cheese made from raw milk
[4].
Brucellosis is a systemic infection in which any
organ or system of the body can be involved.
Cutaneous lesions occur in about 5% of patients
with brucellosis [2]. Ariza et al. [5], in a review of
436 cases of brucellosis, reported that about 6% of
the patients had skin lesions probably caused by
the disease, and described four clinical patterns:
disseminated papulonodular eruption (71%),
nodosum-like erythema (11%), extensive purpura
(7%), and diffuse maculopapular rash (11%).
In this case, the patient had diffuse maculopap-
ular rash. Considering the positive blood cultures,
 2002 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
doxycycline plus rifampin was initiated. As the
patient had not received any drug before the dis-
ease, and had no itching or eosinophilia, a hyper-
sensitivity reaction was considered improbable.
However, the possibility of a immunologically
mediated aetiology cannot be excluded. The
patient rejected skin biopsy, so we could not iso-
late the pathogen from the lesions, although this
has been reported in the literature.
The incidence of disease in Turkey is about
2–6%, and Konya is an endemic area. In endemic
areas, brucellosis should be considered in the
differential diagnosis of patients with dissemi-
nated maculopapular rash.
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